Login

James P. Scriven, CEO of IDB Invest, focuses on Latin American finance and development in collaboration with the International Finance Corporation. 00:10:00

Share On Facebook Share On Twitter

James P. Scriven, CEO of IDB Invest

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Revealing Your True Expense Number: A Simple Test by Kade Hammes | Kade Hammes, Founder, Storybook Financial.
00:00:00
FTC Solar defines its essence and purpose through its identity and mission | SEAN HUNKLER, PRESIDENT AND CHIEF EXECUTIVE OFFICER, FTC SOLAR INC
00:10:00
Cobalt 27: Driving the EV Revolution with Strategic Investments in Battery Metals - Insights from CEO Martin at the One-to-One Mining Investment Conference in New York
00:10:00
Combatting Inflation in Retirement Plans | Hyden Ross, Director, Pathway Financial Planners.
00:10:00
Griffin Mining's Ambitious Exploration Plans in Papua New Guinea
00:10:00
Market Update & Insights | RYAN PARKER - CEO of EP Wealth Advisors
00:10:00
The Future of Machine Learning: Insights with Tristan Zajonc | Tristan Zajonc, CEO , Continual Ltd.
00:10:00
Fred Wagenhals, CEO of Ammo Inc, on Gun Rights, Safety, and GunBroker.com | Fred Wagenhals, CEO, Ammo Inc.
00:00:00
Biophytis sees positive data from PHASE 2-3 COVA CLINICAL STUDY of Sarconeos - Stanislas Veillet , CEO, Biophytis
00:10:00
Unearthing Potential: Allegiant Gold's Strategic Vision and Leadership in Western US Exploration
00:10:00
Victoria Gold: Achieving Records and Expanding Horizons in Yukon's Gold Mining Scene
00:10:00
Chargeurs CEO Michael Fribourg Provides Company Update - Boursorama | Michaël Fribourg - CEO of Chargeurs

© 2017 - Neuhu+